Patent ID: 11954273
Assignee: ABBOTT DIABETES CARE INC.
Field: Medical technology (Instruments)
Classification: CPC G  A  H | IPC A  G  H

Claim 0:
1. A continuous glucose monitoring system, comprising:
(1) a skin-mounted sensor control unit, comprising:
a transcutaneous glucose sensor, a portion of which is configured for transcutaneous positioning in a subcutaneous tissue of a user, and wherein the transcutaneous glucose sensor is configured to sense one or more glucose levels in a body of the user;
an adhesive patch disposed on a bottom surface of the skin-mounted sensor control unit, the adhesive patch configured to adhere the skin-mounted sensor control unit to skin of the user; and
a wireless communication module configured to wirelessly communicate data indicative of the one or more glucose levels to a glucose monitoring device according to a Bluetooth communication protocol; and

(2) the glucose monitoring device, comprising:
a processor;
a transceiver configured for wireless communication with the skin-mounted sensor control unit; and
a user interface controllable by the processor, the user interface comprising a touch screen display configured for tactile contact by the user,

wherein the touch screen display is configured to visually display a graph of the user's one or more glucose levels,
wherein the graph comprises a first axis corresponding to time and a second axis corresponding to the one or more glucose levels, and
wherein the touch screen display is further configured to provide a haptic feedback response in response to incrementing or decrementing, by the user, a selected glucose level of the one or more glucose levels along the first axis corresponding to time.